PATTIES FOODS - Frankfurt Stock Exchang (PH4) - Net Assets
Based on the latest financial reports, PATTIES FOODS - Frankfurt Stock Exchang (PH4) has net assets worth €315.04 Million EUR (≈ $368.32 Million USD) as of June 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€1.19 Billion ≈ $1.39 Billion USD) and total liabilities (€876.86 Million ≈ $1.03 Billion USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check PH4 cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €315.04 Million |
| % of Total Assets | 26.43% |
| Annual Growth Rate | -40.76% |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 26.99 |
PATTIES FOODS - Frankfurt Stock Exchang - Net Assets Trend (2020–2024)
This chart illustrates how PATTIES FOODS - Frankfurt Stock Exchang's net assets have evolved over time, based on quarterly financial data. Also explore how large is PATTIES FOODS - Frankfurt Stock Exchang's balance sheet for the complete picture of this company's asset base.
Annual Net Assets for PATTIES FOODS - Frankfurt Stock Exchang (2020–2024)
The table below shows the annual net assets of PATTIES FOODS - Frankfurt Stock Exchang from 2020 to 2024. For live valuation and market cap data, see PATTIES FOODS - Frankfurt Stock Exchang (PH4) market capitalisation.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | €363.87 Million ≈ $425.40 Million |
-20.35% |
| 2023-12-31 | €456.83 Million ≈ $534.08 Million |
+1.67% |
| 2022-12-31 | €449.33 Million ≈ $525.31 Million |
-62.77% |
| 2021-12-31 | €1.21 Billion ≈ $1.41 Billion |
-59.15% |
| 2020-12-31 | €2.95 Billion ≈ $3.45 Billion |
-- |
Equity Component Analysis
This analysis shows how different components contribute to PATTIES FOODS - Frankfurt Stock Exchang's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 911093400000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Other Components | €9.47 Billion | 2603.89% |
| Total Equity | €363.87 Million | 100.00% |
PATTIES FOODS - Frankfurt Stock Exchang Competitors by Market Cap
The table below lists competitors of PATTIES FOODS - Frankfurt Stock Exchang ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
PMB Technology Bhd
KLSE:7172
|
$891.28 Million |
|
BEH Property Co Ltd
SHG:600791
|
$891.34 Million |
|
Hidrovias do Brasil S.A
SA:HBSA3
|
$891.55 Million |
|
Advanced Wireless Semiconductor Co
TWO:8086
|
$891.55 Million |
|
Hangzhou MDK Opto Electronic Corp. Ltd. A
SHG:688079
|
$891.20 Million |
|
Henan Ancai Hi-tech Co Ltd
SHG:600207
|
$891.05 Million |
|
Irish Continental Group PLC
IR:IR5B
|
$890.98 Million |
|
Sparebanken Sor
OL:SOR
|
$890.43 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in PATTIES FOODS - Frankfurt Stock Exchang's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 456,830,000 to 363,871,000, a change of -92,959,000 (-20.3%).
- Net loss of 91,207,000 reduced equity.
- New share issuances of 74,000 increased equity.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €-91.21 Million | -25.07% |
| Share Issuances | €74.00K | +0.02% |
| Other Changes | €-1.83 Million | -0.5% |
| Total Change | €- | -20.35% |
Book Value vs Market Value Analysis
This analysis compares PATTIES FOODS - Frankfurt Stock Exchang's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 3.46x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has increased from 0.39x to 3.46x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2020-12-31 | €2.52 | €0.99 | x |
| 2021-12-31 | €1.02 | €0.99 | x |
| 2022-12-31 | €0.38 | €0.99 | x |
| 2023-12-31 | €0.36 | €0.99 | x |
| 2024-12-31 | €0.29 | €0.99 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently PATTIES FOODS - Frankfurt Stock Exchang utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -25.07%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -22.40%
- • Asset Turnover: 0.29x
- • Equity Multiplier: 3.83x
- Recent ROE (-25.07%) is above the historical average (-101.35%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2020 | -41.33% | -117.54% | 0.28x | 1.27x | €-1.52 Billion |
| 2021 | -159.08% | -787.84% | 0.11x | 1.88x | €-2.04 Billion |
| 2022 | -200.90% | -187.53% | 0.29x | 3.65x | €-947.61 Million |
| 2023 | -80.39% | -79.17% | 0.28x | 3.64x | €-412.92 Million |
| 2024 | -25.07% | -22.40% | 0.29x | 3.83x | €-127.59 Million |
Industry Comparison
This section compares PATTIES FOODS - Frankfurt Stock Exchang's net assets metrics with peer companies in the Biotechnology industry.
Industry Context
- Industry: Biotechnology
- Average net assets among peers: $698,488,333
- Average return on equity (ROE) among peers: -63.13%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| PATTIES FOODS - Frankfurt Stock Exchang (PH4) | €315.04 Million | -41.33% | 2.78x | $891.27 Million |
| TIZIANA LIFE SCIENCES LTD (0RP) | $5.54 Million | -319.56% | 1.20x | $157.03 Million |
| Theravance Biopharma Inc (0TB) | $441.80 Million | 197.40% | 0.37x | $828.57 Million |
| PreveCeutical Medical Inc (18H) | $-4.10 Million | 0.00% | 0.00x | $3.34 Million |
| Argen-X (1AE) | $538.39 Million | -12.38% | 0.07x | $44.01 Billion |
| WAVE LIFE SCIENCES LTD. (1U5) | $32.50 Million | -376.16% | 5.37x | $1.12 Billion |
| ZAI LAB LTD0000006 (1ZLB) | $1.38 Billion | -51.05% | 0.17x | $2.05 Billion |
| BioNTech SE (22UA) | $493.49 Million | -36.28% | 0.62x | $23.24 Billion |
| Ascletis Pharma Inc (2VJ) | $2.54 Billion | -12.40% | 0.05x | $2.05 Billion |
| ALPHAMAB ONCOLO.DL-000002 (3NK) | $1.56 Billion | -20.91% | 0.36x | $978.26 Million |
| BIOMIND LABS INC. (3XI) | $-247.66K | 0.00% | 0.00x | $3.31 Million |
About PATTIES FOODS - Frankfurt Stock Exchang
CStone Pharmaceuticals, a biopharmaceutical company, researches and develops anti-cancer therapies to address the unmet medical needs of cancer patients in Mainland China and internationally. The company offers CEJEMLY (sugemalimab), a monoclonal antibody against programmed death (PD) ligand 1 for the treatment of non-small cell lung cancer (NSCLC), gastric adenocarcinoma/gastroesophageal junctio… Read more